Wellcome Research Laboratories, South Eden Park Road, Beckenham, Kent BR3 3BS, U.K.; other facilities in Beckenham, Kent, and Dartford, Kent, U.K.; now GlaxoSmithKline plc (GSK); This facility was originally part of Burroughs Wellcome plc, of which the philanthropic Wellcome Foundation was majority owner.; The Foundation divested its holdings, and Glaxo Ltd. and Burroughs Wellcome merged to form Glaxo Wellcome plc; SmithKline Beecham plc merged with Glaxo Wellcome plc in Dec. 2000 to form GSK; This est. license formerly included a West Greenwich, RI, facility used for manufacture of interferon (now used by Immunex/Amgen for manufacture of Enbrel). The ‘Wellcome Foundation’ name is still used by FDA for this establishment license.
